Development and Evaluation of High-Concentration Human Immune Globulin Suspension Formulations

Abstract

The development of high-concentration human immune globulin suspension formulations requires a deep understanding of formulation strategies, injectability challenges, and colloidal stability. This study investigates the impact of spray drying, excipient-induced protein saturation, concentration-injection force relationships, viscosity behavior, and clinical implications of non-Newtonian suspensions. A quantitative research methodology was employed, analyzing independent variables such as spray drying conditions, excipient concentrations, and formulation parameters against dependent variables including particle size distribution, protein solubility, injection force, and viscosity. The results demonstrate that optimized spray drying significantly improves particle size uniformity, pharmaceutical excipients enhance protein solubility while maintaining stability, higher concentration suspensions require greater injection force, viscosity increases with concentration affecting injectability, and formulation strategies can mitigate injectability challenges to enhance clinical viability. The findings contribute to improved formulation techniques for injectable high-viscosity suspensions, addressing gaps in drug delivery and biopharmaceutical manufacturing. Future research should explore long-term stability, forced degradation, and regulatory considerations for clinical translation.